Skip to main content

Thought Leadership

DisposeRx CEO Warns Medication Safety Gap Persists After Treatment Ends

Image
DisposeRx CEO Warns Medication Safety Gap Persists After Treatment Ends

Southern Pines, N.C. – – October 02, 2026 -- DisposeRx CEO William Simpson is pressing the healthcare industry to extend medication safety protocols beyond the point of prescribing, arguing that leftover drugs left in home medicine cabinets create unmanaged risk once a treatment course concludes.

Simpson says current safety standards stop short of covering the full prescription life-cycle.

In a new commentary, Simpson questions whether the same rigor applied when a patient begins therapy is matched when a condition improves, a dosage changes, one medication replaces another, a physician deprescribes a no-longer-necessary therapy, an antibiotic course ends, or a patient is discharged from the hospital with an altered regimen.